Related Experiment Video
Updated: Dec 20, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Association of hypertension with the severity and fatality of SARS-CoV-2 infection: A meta-analysis
Jingqi Zhang1, Jing Wu1, Xiaohua Sun2
1Department of Epidemiology and Statistics, School of Public Health, Jiangsu Key Laboratory and Translational Medicine for Geriatric Disease, Medical College of Soochow University, Soochow, China.
Insights
Hypertension significantly increases the risk of severe COVID-19 illness and death. This meta-analysis confirms that individuals with high blood pressure face a higher likelihood of critical outcomes from SARS-CoV-2 infection.
Area of Science:
- Infectious Diseases
- Cardiovascular Medicine
- Public Health
Background:
- Hypertension is a prevalent comorbidity among patients diagnosed with COVID-19.
- The precise relationship between hypertension and the severity or fatality of SARS-CoV-2 infection requires further clarification.
Purpose of the Study:
- To conduct a meta-analysis evaluating the impact of hypertension on COVID-19 severity and fatality.
- To synthesize evidence from published studies to quantify the risks associated with hypertension in COVID-19 patients.
Main Methods:
- A systematic literature search was performed across multiple databases (PubMed, Elsevier, Web of Science, Wiley, Embase, CNKI) up to March 20, 2020.
- Meta-analysis included 12 publications for severity (2389 patients) and six studies for fatality (2116 patients).
- Pooled odds ratios (ORs) and confidence intervals (CIs) were calculated to assess the association between hypertension and COVID-19 outcomes.
Main Results:
- Hypertensive COVID-19 patients exhibited a significantly higher severity rate (37.58%) compared to non-hypertensive patients (19.73%; pooled OR: 2.27).
- Hypertension increased the risk of COVID-19 fatality by approximately 3.48-fold (95% CI: 1.72-7.08).
- Increased risks for severity and fatality were observed across different age groups (<50 and ⩾50 years).
Conclusions:
- Hypertension is a significant risk factor for both increased severity and higher fatality rates in SARS-CoV-2 infection.
- The findings underscore the importance of managing hypertension in the context of COVID-19.
- No significant heterogeneity or publication bias was detected, strengthening the study's conclusions.
Abstract:
Hypertension is a common comorbidity in COVID-19 patients. However, the association of hypertension with the severity and fatality of COVID-19 remain unclear. In the present meta-analysis, relevant studies reported the impacts of hypertension on SARS-CoV-2 infection were identified by searching PubMed, Elsevier Science Direct, Web of Science, Wiley Online Library, Embase and CNKI up to 20 March 2020. As the results shown, 12 publications with 2389 COVID-19 patients (674 severe cases) were included for the analysis of disease severity. The severity rate of COVID-19 in hypertensive patients was much higher than in non-hypertensive cases (37.58% vs 19.73%, pooled OR: 2.27, 95% CI: 1.80-2.86). Moreover, the pooled ORs of COVID-19 severity for hypertension vs. non-hypertension was 2.21 (95% CI: 1.58-3.10) and 2.32 (95% CI: 1.70-3.17) in age <50 years and ⩾50 years patients, respectively. Additionally, six studies with 151 deaths of 2116 COVID-19 cases were included for the analysis of disease fatality. The results showed that hypertensive patients carried a nearly 3.48-fold higher risk of dying from COVID-19 (95% CI: 1.72-7.08). Meanwhile, the pooled ORs of COVID-19 fatality for hypertension vs. non-hypertension was 6.43 (95% CI: 3.40-12.17) and 2.66 (95% CI: 1.27-5.57) in age <50 years and ⩾50 years patients, respectively. Neither considerable heterogeneity nor publication bias was observed in the present analysis. Therefore, our present results provided further evidence that hypertension could significantly increase the risks of severity and fatality of SARS-CoV-2 infection.
Related Concept Videos
Hypertension II: Pathophysiology
Hypertension III: Clinical Manifestations and Diagnostic Studies
Coronary Artery Disease I: Introduction
Hypertension I: Introduction
Heart Failure II: Pathophysiology
Hypertension and Regulation of Blood Pressure